Senior Manager/Associate Director, Scientific Communications

About Avalyn Avalyn aims to transform the treatment paradigm for pulmonary fibrosis and other serious, rare respiratory diseases. The company is advancing optimized inhaled formulations of established antifibrotic medicines designed to deliver drug directly to the lungs, enhance local efficacy, and reduce systemic side effects. Avalyn’s AP01 program is an optimized inhaled formulation of pirfenidone currently being evaluated in MIST, a global Phase 2b clinical trial in patients with progressive pulmonary fibrosis (PPF). AP01 has demonstrated encouraging safety and clinical activity across Phase 1b and an ongoing, multi-year open-label extension trial, with long-term data supporting the potential to preserve lung function while improving tolerability relative to historical oral pirfenidone. Avalyn’s AP02 program is an optimized inhaled formulation of nintedanib currently being evaluated in AURA, a global Phase 2 clinical trial in patients with idiopathic pulmonary fibrosis (IPF). Avalyn is also advancing AP03, an inhaled fixed-dose combination of pirfenidone and nintedanib, designed to deliver multiple antifibrotic mechanisms through a single lung-targeted platform. By leveraging its proprietary drug-device approach and deep expertise in rare respiratory disease development, Avalyn aims to establish a new standard of care in pulmonary fibrosis through inhaled, lung-targeted therapies. For more information, please visit avalynpharma.com and follow the company on LinkedIn . Position Overview The Senior Manager/Associate Director, Scientific Communications will play an integral role in the development and execution of Avalyn's scientific communications strategy, with a particular emphasis on medical congress planning, scientific exchange, publication support, and medical affairs content development. Reporting to the Director, Scientific Communications & Medical Education, this position will partner closely with Medical Affairs, Clinical Development, Regulatory Affairs, Corporate Communications, and external vendors to ensure consistent, accurate, and impactful scientific communication of Avalyn's clinical and scientific data. Success in this role will be demonstrated through the flawless execution of annual congress strategies, timely delivery of high-quality scientific communication materials, successful management of publication and presentation activities, and establishment of strong relationships with internal and external stakeholders. This individual will thrive in a fast-paced biotech environment and bring a solutions-oriented, hands-on approach to advancing Avalyn's medical affairs objectives. Key Responsibilities Scientific Communications Strategy & Execution Support the development and implementation of scientific communication plans aligned with overall Medical Affairs and corporate objectives. Collaborate with the Director of Scientific Communications to execute scientific communication activities across Avalyn's portfolio. Assist in the development and maintenance of scientific platforms, core slide decks, FAQs, scientific narratives, disease state education materials, and other Medical Affairs resources. Ensure scientific consistency and accuracy across all medical communication materials. Coordinate cross-functional review and approval processes for scientific communication deliverables, to include Medical/Legal/Regulatory review. Congress Planning & Scientific Meetings (Primary Focus) Lead operational planning and execution for key national and international medical congresses, including ATS, ERS, CHEST, and other relevant pulmonary and ILD meetings. Develop annual congress plans, timelines, and budgets in partnership with Medical Affairs leadership. Lead regularly scheduled cross-functional congress planning meetings. Coordinate congress-related activities, including scientific booths and medical information materials, advisory boards, investigator meetings, medical affairs events, sponsored symposia, congress lo…